At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 users were 37% higher than in users of so-called SGLT-2 drugs and 68% higher versus DPP-4 drugs, researchers at the University of Pennsylvania reported Wednesday in The BMJ
Santra M, Zhang ZG, Yang J, Santra S, Santra S, Chopp M, Morris DC
Verify availability in your area before beginning the intake process
The two subspecies are the bronze frog and the northern green frog
UpToDate: Accessed Jan
But, thinking about what we do, I feel good about navigating patients towards the best available treatment for them." Botta also is concerned about patients' access to "life-changing" weight loss medications if supply issues aren't resolved